Prof. Takashi Yamamura MD, PhD National Institute of Neuroscience, NCNP Tokyo | Japan
Takashi Yamamura graduated Kyoto University, Faculty of Medicine in 1980, and received MD, PhD from Kyoto University. After completing the clinical and research training in Japan, he worked at Max-Planck Society, Wurzburg, Germany (1987-1989), and at Harvard Medical School (1989-1990) as a research fellow. In 1990, he was appointed as Section Chief and then promoted to be Director of the Department of Immunology, in the National Institute of Neuroscience, NCNP, Tokyo. He has also been serving as Director of Multiple Sclerosis Center, NCNP, since 2010.
Dr. Yamamura’s main interests are the immunological pathogenesis of multiple sclerosis (MS) and neuromyelitis optica (NMO), and development of new treatment options for these disorders. He is a pioneer for the development of anti-IL-6 receptor antibody treatment for NMO, and is currently involved in an investigator-initiated clinical trial. He received 6th Human Immunology Research Award from Japanese Society of Immunology in 2019. He was awarded Human Science research grant for sabbatical leave, and stayed at the Weizmann Institute of Science, Israel, in 1995.
He is an international advisory board member of ISNI, past co-chair or Federation of Clinical Immunology Societies (FOCiS) (2007), Vice President of 5th International Symposium on CD1/NKT cells (2009), and Congress President for Japanese Society for Neuroimmunology (2010) and for Japanese Society for Clinical Immunology (2013). Over 150 original papers from his group were published in high-ranked journals including Nature, New England Journal of Medicine, Nature Immunology, JCI, Nature Communications, PNAS and BRAIN.